Insider: Audhya Paul K. CHIEF MEDICAL OFFICER - KalVista Pharmaceuticals, Inc.
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 122,505 | 0 | 122,505 |
| Value | $1,519,062.00 | $0.00 | $1,519,062.00 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 08/25/2025 | DDS | 2,336 | Direct | COM | $13.42 | $31,349.12 | 122,505 |
| 08/22/2025 | DDS | 2,942 | Direct | COM | $13.22 | $38,901.48 | 119,841 |
| 08/18/2025 | DDS | 2,939 | Direct | COM | $13.19 | $38,756.59 | 116,533 |
| 05/23/2025 | DDS | 2,146 | Direct | COM | $11.31 | $24,271.69 | 113,026 |
| 05/22/2025 | DDS | 2,689 | Direct | COM | $11.88 | $31,933.22 | 110,172 |
| 05/19/2025 | DDS | 2,776 | Direct | COM | $11.84 | $32,875.61 | 106,611 |
| 02/24/2025 | DDS | 2,394 | Direct | COM | $10.02 | $23,987.88 | 102,940 |
| 02/18/2025 | DDS | 3,125 | Direct | COM | $9.82 | $30,700.63 | 100,334 |
| 11/26/2024 | DDS | 2,187 | Direct | COM | $9.87 | $21,586.13 | 97,012 |
| 11/18/2024 | DDS | 8,077 | Direct | COM | $9.26 | $74,765.56 | 94,199 |
| 08/23/2024 | DDS | 2,135 | Direct | COM | $12.40 | $26,474.00 | 83,745 |
| 08/19/2024 | DDS | 7,973 | Direct | COM | $12.01 | $95,782.04 | 80,880 |
| 05/20/2024 | DDS | 13,175 | Direct | COM | $11.76 | $154,997.29 | 70,325 |
| 02/20/2024 | DDS | 14,295 | Direct | COM | $14.12 | $201,773.93 | 52,886 |
| 11/20/2023 | DDS | 7,985 | Direct | COM | $8.23 | $65,710.96 | 36,568 |
| 08/18/2023 | DDS | 8,020 | Direct | COM | $10.73 | $86,044.98 | 26,023 |
| 05/18/2023 | DDS | 2,780 | Direct | COM | $10.14 | $28,201.43 | 13,014 |
| 11/18/2022 | DDS | 722 | Direct | COM | $5.44 | $3,927.68 | 5,946 |
| 08/17/2022 | DDS | 725 | Direct | COM | $14.96 | $10,847.09 | 1,693 |
| 1 You are at page 1 of 1 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2025 Zacks Investment Research